MFDS — authorised 9 September 2022
- Marketing authorisation holder: BRISTOL-MYERS SQUIBB
- Status: likely_approved
🇰🇷 Sotyktu in South Korea
MFDS authorised Sotyktu on 9 September 2022
Marketing authorisation
Sotyktu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Sotyktu approved in South Korea?
Yes. MFDS authorised it on 9 September 2022.
Who is the marketing authorisation holder for Sotyktu in South Korea?
BRISTOL-MYERS SQUIBB holds the South Korean marketing authorisation.